Sitryx Therapeutics

Description: Sitryx develops immunometabolism therapies for immuno-oncology & inflammation, backed by $30M Series A funding. Based in Oxford, UK.

Country: UK

Based in: Oxford

Founded: 2018

Funding Stage: Series A/B

Tags: ['Biotechnology', 'Health Care', 'Pharmaceutical']

Categories

Add insights to your inbox

We’ll send you content you’ll want to read- and put to use.

Details about how we process your information are available in our Privacy Policy.